ReviewPharmacy (Basel, Switzerland)2025
Targeting Amyloid Pathology in Early Alzheimer's: The Promise of Donanemab-Azbt.
Nadia Khartabil et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it